Lehman TA - Search Results

1

Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53.

Byrd JC, Shinn C, Waselenko JK, Fuchs EJ, Lehman TA, Nguyen PL, Flinn IW, Diehl LF, Sausville E, Grever MR. Byrd JC, et al. Among authors: lehman ta. Blood. 1998 Nov 15;92(10):3804-16. Blood. 1998. PMID: 9808574 Free article.

2

Fc gamma RIIIa and Fc gamma RIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia.

Farag SS, Flinn IW, Modali R, Lehman TA, Young D, Byrd JC. Farag SS, et al. Among authors: lehman ta. Blood. 2004 Feb 15;103(4):1472-4. doi: 10.1182/blood-2003-07-2548. Epub 2003 Oct 16. Blood. 2004. PMID: 14563637 Free article. Clinical Trial.

3

FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia.

Lin TS, Flinn IW, Modali R, Lehman TA, Webb J, Waymer S, Moran ME, Lucas MS, Farag SS, Byrd JC. Lin TS, et al. Among authors: lehman ta. Blood. 2005 Jan 1;105(1):289-91. doi: 10.1182/blood-2004-02-0651. Epub 2004 Jun 24. Blood. 2005. PMID: 15217834 Free article. Clinical Trial.

4

UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism.

Byrd JC, Shinn C, Willis CR, Flinn IW, Lehman T, Sausville E, Lucas D, Grever MR. Byrd JC, et al. Exp Hematol. 2001 Jun;29(6):703-8. doi: 10.1016/s0301-472x(01)00649-x. Exp Hematol. 2001. PMID: 11378265 Free article.

5

Dopamine D2 receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial.

Murphy G, Cross AJ, Sansbury LS, Bergen A, Laiyemo AO, Albert PS, Wang Z, Yu B, Lehman T, Kalidindi A, Modali R, Schatzkin A, Lanza E. Murphy G, et al. Int J Cancer. 2009 May 1;124(9):2148-51. doi: 10.1002/ijc.24079. Int J Cancer. 2009. PMID: 19065655 Free PMC article. Clinical Trial.

6

Polynucleotide kinase 3' phosphatase variant, dietary variables and risk of adenoma recurrence in the Polyp Prevention Trial.

Murphy G, Sansbury LS, Bergen AW, Wang Z, Schatzkin A, Lehman T, Kalidindi A, Modali R, Lanza E. Murphy G, et al. Eur J Cancer Prev. 2008 Jun;17(3):287-90. doi: 10.1097/CEJ.0b013e3282b6fdb8. Eur J Cancer Prev. 2008. PMID: 18414202 Free PMC article. Clinical Trial.

7

Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial.

Murphy G, Sansbury LB, Cross AJ, Stolzenberg-Solomon R, Laiyemo A, Albert PS, Wang Z, Schatzkin A, Lehman T, Kalidindi A, Modali R, Lanza E. Murphy G, et al. Cancer Causes Control. 2008 Sep;19(7):751-8. doi: 10.1007/s10552-008-9137-6. Epub 2008 Mar 6. Cancer Causes Control. 2008. PMID: 18322814

8

Screening of mutations in the ras family of oncogenes by polymerase chain reaction-based ligase chain reaction.

Martínez A, Lehman TA, Modali R, Mulshine JL. Martínez A, et al. Among authors: lehman ta. Methods Mol Med. 2003;74:187-200. doi: 10.1385/1-59259-323-2:187. Methods Mol Med. 2003. PMID: 12415694 No abstract available.

9

Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.

Lehman TA, Haffty BG, Carbone CJ, Bishop LR, Gumbs AA, Krishnan S, Shields PG, Modali R, Turner BC. Lehman TA, et al. Cancer Res. 2000 Feb 15;60(4):1062-9. Cancer Res. 2000. PMID: 10706125

10

Oncogenes and tumor suppressor genes involved in human lung carcinogenesis.

Harris CC, Reddel R, Modali R, Lehman TA, Iman D, McMenamin M, Sugimura H, Weston A, Pfeifer A. Harris CC, et al. Among authors: lehman ta. Basic Life Sci. 1990;53:363-79. doi: 10.1007/978-1-4613-0637-5_29. Basic Life Sci. 1990. PMID: 2282044 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters